THE WEEK Health Summit 2026: Why early screening is vital to slowing chronic kidney disease progression
While artificial intelligence can assist clinicians in processing data, proper medical management, dietary adjustments, and human judgment remain central to patient care
Experts at a recent health summit highlighted the importance of early screening, lifestyle management, and routine testing to combat the silent crisis of chronic kidney disease.
Experts at a recent health summit highlighted the importance of early screening, lifestyle management, and routine testing to combat the silent crisis of chronic kidney disease.
Experts at a recent health summit highlighted the importance of early screening, lifestyle management, and routine testing to combat the silent crisis of chronic kidney disease.
Chronic kidney disease (CKD) is often called a silent crisis because it can progress without obvious symptoms until kidney function has deteriorated significantly. At THE WEEK Health Summit 2026, held at the Ambassador Hotel, nephrologists stressed that early screening, awareness and sustained care are essential to prevent the disease from reaching an advanced stage.
Dr Sanjiv Jasuja, senior nephrologist at Apollo Hospitals, said lifestyle-related conditions were contributing to the burden of kidney disease. He said around seven out of every 100 people could be vulnerable, making routine testing important. By the time symptoms appear, some patients may have reached a stage where treatment options are limited and intensive interventions become necessary.
Jasuja said exercise and management of underlying conditions were important for prevention and treatment. India, he added, had a growing transplant system and several options for patients with advanced disease. Medical management, however, remained central to caring for people with CKD.
Talking about AI tools, he said it can help clinicians process information and make their work easier, but medical decisions still require judgement and a human connection. “Let AI not take your job; let it be your friend,” he said, urging healthcare professionals to use the technology judiciously.
Jasuja also underlined the need to modify protein intake for people with kidney disease. The appropriate amount depends on the patient's condition, he said, and dietary advice must be adjusted accordingly.
Dr Narin Sehgal of NEO Hospital said CKD often goes unnoticed unless people undergo screening. Those with diabetes or hypertension, and people who regularly take painkillers, should be particularly vigilant and undergo essential tests, he said.
Sehgal identified the glomerular filtration rate (GFR) and urine albumin-to-creatinine ratio as important tests. GFR indicates how effectively the kidneys filter blood, while the urine test can detect protein leakage, which may signal kidney damage. Screening can identify the disease early, when its progression may be slowed through appropriate treatment.
He said there was a significant window between the early stages of CKD and end-stage kidney disease. Controlling diabetes and other underlying conditions, alongside appropriate medication, could help preserve kidney function. Some newer drugs can help selected patients, although they are not suitable for everyone. Their costs may also fall as use increases and more companies enter the market.
Sehgal said awareness, education and screening must be priorities, followed by long-term care for those diagnosed with CKD. Dialysis can disrupt daily life, but with counselling and support, patients can adapt and continue to lead active lives, although outcomes vary.
The panel’s message was that kidney disease should not be left to announce itself. Regular testing among at-risk people, timely treatment and sustained support can make a difference.